AMPH
Amphastar Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $1.29B | Price | $25.50 |
| Volume | 552.33K | Change | +3.41% |
| P/E Ratio | 8.1 | Open | $24.36 |
| Revenue | $732.0M | Prev Close | $24.66 |
| Net Income | $159.5M | 52W Range | $20.39 - $53.96 |
| Div Yield | N/A | Target | $32.50 |
| Overall | 69 | Value | 80 |
| Quality | 63 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyAmphastar Pharmaceuticals Inc. (AMPH) is a leading Healthcare company in the Drug Manufacturers - Specialty & Generic industry, currently trading at $25.50 with a market capitalization of $1.29 billion. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating solid quality metrics with a MarketXLS quality score of 63.
Today's trading session shows AMPH with a volume of 552K shares. The stock opened down 1.22% from yesterday's close of $24.66. Current analyst estimates project earnings of $3.09 per share for this year, with next year targeting $3.31.
AMPH demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including MRNS, SCYX, AGRX, TNXP.
Key investment considerations for AMPH include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 27.5%. The stock shows attractive valuation opportunity based on valuation analysis.
Analysis generated on November 3, 2025 at 09:41 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AMPH | $25.50 | +3.4% | 552.33K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Amphastar Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW